Examinant per Autoria "Carcereny, Enric"
Mostrant 1 - 2 de 2
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach(Impact Journals, 2021) Carcereny, Enric; Fernández Nistal, Alonso; López, Araceli; Montoto, Carmen; Naves, Andrea; Segú-Vergés, Cristina; Coma Camprodón, Mireia; Jorba Argemí, Guillem; Oliva Miguel, Baldomero; Mas, José Manuel
Ítem Accés Obert ROS1 copy number alterations are frequent in non-small cell lung cancer(Impact Journals, 2014) Clavé Safont, Sergi; Gimeno Beltran, Javier; Muñoz-Mármol, Ana M.; Vidal Barrull, Joana; Reguart, Noemí; Carcereny, Enric; Pijuan Andujar, Lara; Menendez Romero, Silvia; Taus García, Álvaro; Mate, José Luís; Serrano Figueras, Sergi; Albanell Mestres, Joan; Espinet Solà, Blanca; Arriola Aperribay, Edurne; Salido Galeote, Marta